EXAGEN INC. - COMMON STOCK

Exagen Inc. Reports Second Quarter 2022 Results

04 авг 2022 16:05:01 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

25 июл 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022

21 июл 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility

05 июл 2022 08:25:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with MediNcrease

09 июн 2022 08:25:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference

26 май 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus

16 май 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

11 май 2022 16:06:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports First Quarter 2022 Results

11 май 2022 16:05:01 Источник Nasdaq GlobeNewswire

Exagen Announces Five-Week Campaign for Lupus Awareness Month

01 май 2022 12:00:00 Источник Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022

25 апр 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference

20 апр 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

30 мар 2022 08:25:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

22 мар 2022 16:06:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results

22 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

16 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

09 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022

08 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

02 фев 2022 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection

09 янв 2022 12:00:00 Источник Nasdaq GlobeNewswire